Pharmacoeconomic analyses: making them transparent, making them credible

JAMA. 2000 Apr 26;283(16):2158-60. doi: 10.1001/jama.283.16.2158.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Clinical Trials as Topic
  • Cost-Benefit Analysis
  • Drug Costs
  • Economics, Pharmaceutical*
  • Models, Economic
  • Peer Review